IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Posted on August 2, 2018 in Spotlighted

IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence for Commercialization and Research program (CECR).